Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients

Published:2010-11-12 Issue:2 Volume:13 Page:195-202
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro-Oncology

Author:

Park C.-K.,Kim J.,Yim S. Y.,Lee A. R.,Han J. H.,Kim C.-Y.,Park S.-H.,Kim T. M.,Lee S.-H.,Choi S. H.,Kim S.-K.,Kim D. G.,Jung H.-W.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/13/2/195/3827324/noq162.pdf

Reference22 articles.

1. Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

2. Population-Based Study of Pseudoprogression after Chemoradiotherapy in GBM

3. MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

4. Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements

5. New advances that enable identification of glioblastoma recurrence

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patients;2024-09-08

2. Radiogenomics-Based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance;Genes;2024-06-01

3. Predominance of MGMT promoter methylation among Pakistani glioblastoma patients;Molecular Biology Reports;2024-03-23

4. Adjuvant Temozolomide Chemotherapy With or Without Interferon Alfa Among Patients With Newly Diagnosed High-grade Gliomas;JAMA Network Open;2023-01-27

5. Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance;International Journal of Cancer;2022-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3